2016 Essen: TheraSphere™ training program (Yttrium-90 Glass Microspheres)
ILS (Immediate Life Support) certificate & BLS/AED Instructor certificate
Palliative care course provided by St. Christopher’s Oncology Hospice Foundation
Communication Skills and Health System Management course organised by The Polish Chamber of Physicians
EACH (European Association for Communication in Healthcare) Train The Trainers course: What and how to teach, Curriculum Development in Communication Skills Teaching
[PI] SAPPHIRE (120-CX-202): A Phase 2, Multicenter, Randomized, Double-blind, Placebo- controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants with Colorectal Cancer who have Cancer Cachexia
[PI] VINCIT (CTL-002-006): Adaptive, Phase 2/3, Randomized, Double-Blind Trial Investigating the Efficacy and Safety of Visugromab versus Placebo in Patients with Cancer- associated Cachexia
RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors
IO102-IO103-013 (IOB-013) / MK3475-D18 (KN-D18): An open-label, randomized, Phase 3 clinical trial of IO102-IO103 in combination with pembrolizumab versus pembrolizumab alone in patients with previously untreated, unresectable, or metastatic (advanced) melanoma
MONETTE: A Randomised, Open-Label, Phase 2 Study of Ceralasertib Monotherapy and Ceralasertib plus Durvalumab in Patients with Unresectable or Advanced Melanoma and Primary or Secondary Resistance to PD-(L)1 Inhibition
BNT111-01: An open-label, randomized Phase II trial with BNT111 and cemiplimab in combination or as single agents in patients with anti-PD1-refractory/relapsed, unresectable Stage III or IV melanoma
EORTC-2139 COLUMBUS Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma with a BRAF Mutation.
